Results The entire database incorporates 1,065 gastric carcinoma samples, gene expression
data. Out of 29 established markers, higher expression of BECN1 (HR= 0.68, p= 1.5 E-05), …

Objective Gastric cancer is a major gastrointestinal malignancy for which targeted therapies
are emerging as treatment options. This study sought to identify the most prevalent …

Germline CDH1 mutations confer a high lifetime risk of developing diffuse gastric (DGC) and
lobular breast cancer (LBC). A multidisciplinary workshop was organised to discuss genetic …

Hereditary diffuse gastric cancer (HDGC) is an autosomal dominant cancer syndrome that is
characterised by a high prevalence of diffuse gastric cancer and lobular breast cancer. It is …

Background & Aims Almost all gastric cancers are adenocarcinomas, which have
considerable heterogeneity among patients. We sought to identify subtypes of gastric …

Many solid cancers are known to exhibit a high degree of heterogeneity in their deregulation
of different oncogenic pathways. We sought to identify major oncogenic pathways in gastric …

Among the cytokines linked to inflammation-associated cancer, interleukin (IL)-6 drives
many of the cancer "hallmarks" through downstream activation of the gp130/STAT3 signaling …

BACKGROUND & AIMS: Gastric cancer (GC) is a heterogeneous disease comprising
multiple subtypes that have distinct biological properties and effects in patients. We sought to …

Objectives To determine the accuracy and acceptability to patients of non-endoscopic
screening for Barrett’s oesophagus, using an ingestible oesophageal sampling device (…

The latent transcription factor Stat3 is activated by gp130, the common receptor for the
interleukin (IL)-6 cytokine family and other growth factor and cytokine receptors. Ligand-induced …